Ligand · QDZ
QDZ · ~{N},~{N}-dimethyl-1-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]methanamine
QDZ, ~{N},~{N}-dimethyl-1-[1-[2-(1-methylindol-4-yl)-3~{H}-imidazo[4,5-b]pyridin-7-yl]pyrazol-4-yl]methanamine (C21 H21 N7, 371.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- QDZ
- Formula
- C21 H21 N7
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
QDZ in 2 structures; the first of them:
- 6ZC0 · SYK Kinase domain in complex with azabenzimidazole inhibitor 2b · QDZ A701 · binds LEU377, GLY378, VAL385, ALA400, LYS402, VAL433, MET448, GLU449 and 11 more
- 6ZC0 · Syk kinase domain in complex with azabenzimidazole inhibitor 2B · QDZ A701 · binds LEU377, VAL385, ALA400, LYS402, VAL433, MET448, GLU449, MET450 and 9 more
Residues it binds most
LEU 2, ALA 2, GLU 2, MET 2, VAL 2, GLY 2, ARG 2, ASN 2, ASP 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.